ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function
Tetsuro Murakami(University of Toronto), Peter St George‐Hyslop(University of Cambridge), Gerold Schmitt‐Ulms(University of Toronto), Claire H. Michel(University of Cambridge), William Meadows(University of Cambridge), Yosuke Wakutani(University of Toronto), Michele Vendruscolo(University of Cambridge), Eric J. Rees(University of Cambridge), Rodylyn Rose Ferry(University of Toronto), Giorgio Favrin(University of Cambridge), Gian Gaetano Tartaglia(Institució Catalana de Recerca i Estudis Avançats), Seung‐Pil Yang(University of Toronto), Seema Qamar(University of Cambridge), Gabriele S. Kaminski Schierle(University of Cambridge), Mei Zhen(Lunenfeld-Tanenbaum Research Institute), Clemens F. Kaminski(University of Cambridge), Julie Qiaojin Lin(University of Hong Kong), Ana Rita Costa(University of Cambridge), David Ron(Institute for Medical Research), Christine E. Holt(University of Cambridge), Neil A. Shneider(Columbia University Irving Medical Center), Akinori Miyashita(University of Toronto), Roger B. Dodd(University of Cambridge), Yi Li(Houston Methodist Sugar Land Hospital), Liang Dong(University of Cambridge), Wen-Lang Lin(Jacksonville College), Fiona T.S. Chan(University of Cambridge), Paul E. Fraser(University of Toronto), Deborah Kronenberg‐Versteeg(University of Cambridge), Dennis W. Dickson(Jacksonville College)
Cited by 917
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
|Neurology|1993|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k